Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Impact of Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil on Diabetic Erectile Dysfunction. (PilatesDED2025)

13 novembre 2026 aggiornato da: Mahmoud Hamada Mohamed, Benha University

Pilates Exercises Added to Pelvic Floor Muscle Training and Sildenafil for Diabetic Erectile Dysfunction: A Randomized Controlled Trial

Erectile dysfunction (ED) has a prevalence of 52.5% in diabetic male patients, as described in a meta-analysis of 145 studies, including 88,577 men with type 1 and type 2 diabetes.

In men, ED can cause sexual dissatisfaction and distress, unsatisfactory relationships, and marital tension

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Pilates emerged as a method of rehabilitation during World War I, when Joseph Hubertus Pilates applied his knowledge to rehabilitate injured men. The popularity of the method grew most in the 1980. More recently, Pilates has been used resulting in improved fitness (flexibility, strength and balance) and body consciousness. The method features ground-based exercises created by Joseph Pilates.

Because most Pilates exercises are performed in conjunction with the recruitment of PF muscle fibres, many Pilates instructors believe that the method can produce a significant increase in the force or contractility of the muscles. Furthermore, if Pilates promotes an improvement in the functioning of the pelvic floor muscles (PFM), it may be an alternative for the treatment and prevention of pelvic floor dysfunction.

Up till now, no published trials about impact of Pilate exercises on diabetic erectile dysfunction.

A total of 60 patients (n=30 per group), diagnosed with diabetic erectile dysfunction in the past 6 months. Participants will be recruited from Benha University hospital and local andrology and urology clinics in benha and giza . Participants will be screened for eligibility prior to being enrolled in the study participating in the study assessments.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Benha
      • Banhā, Benha, Egitto
        • Outpatient clinic, faculty of Physical Therapy, Benha university

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 40 anni a 60 anni (Adulto)

Accetta volontari sani

No

Sessi ammissibili allo studio

Maschio

Descrizione

Inclusion Criteria:

  • Men aged 40-60 years.
  • Married.
  • Diagnosed with type 2 diabetes mellitus for >5 years, with initial diagnosis confirmed by HbA1c >6.5%.
  • Arteriogenic erectile dysfunction (ED) of >6 months' duration, diagnosed using the International Index of Erectile Function-5 (IIEF-5),confirmed by penile Doppler ultrasonography showing peak systolic velocity (PSV) of the cavernosal arteries <25 cm/s.
  • Body mass index (BMI) <30 kg/m².

Exclusion Criteria:

  • Poorly controlled diabetes mellitus (HbA1c >9%).
  • Neurogenic, venogenic, or psychogenic ED.
  • Cardiac conditions contraindicating sexual activity.
  • Neurological disorders or spinal cord injury.
  • Alcohol abuse or illicit drug use.
  • Chronic hematological disorders.
  • Active genitourinary infection.
  • Severe hypogonadism.
  • History of radical prostatectomy, pelvic surgery, or pelvic trauma.
  • Penile prosthesis implantation.
  • Current or previous participation in a structured pelvic floor muscle training or sexual rehabilitation program.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Sperimentale

The program had 11 mat exercises: Pilates breathing, spine stretch, swan, shoulder bridge, hundreds, double leg stretch, footwork, roll up, single leg stretch, leg pull back, and kick front and back, It had three phases of four weeks each. In the beginner phase (weeks 1 to 4), participants did one set of six to eight repetitions of each exercise, using supported positions and modified movements to establish breathing coordination and lumbopelvic control. In the intermediate phase (weeks 5 to 8), they did two sets of eight to 10 repetitions with larger movement amplitude, longer lever arms, and more challenging limb movements. In the advanced phase (weeks 9 to 12), they did two sets of 10 to 12 repetitions of more complex variations with greater stabilization demands, provided they kept adequate movement control.

Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary.

Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period.

Comparatore attivo: Comparatore attivo

Participants attended an educational session conducted by a physiotherapist covering pelvic floor anatomy, the physiology of erection, and the roles of the ischiocavernosus and bulbocavernosus muscles in erectile function. They were instructed on proper pelvic floor muscle contraction using simulated interruption of urine flow and maximal voluntary contractions. A home-based PFMT program was prescribed, initially performed in the supine position with knees flexed and subsequently progressed to sitting or standing positions as tolerated. Participants were instructed to perform PFMT twice daily (morning and evening), consisting of 15 short contractions (1 second each) and 15 sustained contractions (6-10 seconds each). Adherence was monitored through a mobile messaging application, via which participants reported completion of their daily exercises and received reminders when necessary.

Participants received sildenafil citrate 25 mg orally once daily and sildenafil citrate 50 mg orally on demand, taken approximately 1 hour before sexual intercourse, throughout the study period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
International Index of Erectile Function-5 (IIEF-5) scale.
Lasso di tempo: Baseline and after 12 weeks

The IIEF-5 scale is used to assess patients with erectile dysfunction to determine the extent of the erectile function in patients. The full-scale 15-item version has five domains: erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall sexual satisfaction.

The shortened 5-item version is on a scale of 5 to 25:

22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunction

Baseline and after 12 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
penile perfusion
Lasso di tempo: Base line and after 12 weeks

Colour-coded duplex sonography (5-10 MHz probes) will be used for the evaluation of penile perfusion. Half ml of a vasoactive agent (trimix solution) will be injected into the corpus cavernosum. The systolic and diastolic velocities (cm/s) will be performed at 10 and 30 min for both cavernous artery. Re-dosing with 0.5 ml of trimax solution will be performed for patients who did not achieve adequate hardness. The highest values obtained will be recorded. The Doppler indices of the right and left cavernous arteries: peak systolic velocity (PSV)

Base line and after 12 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

15 dicembre 2025

Completamento primario (Effettivo)

22 giugno 2026

Completamento dello studio (Effettivo)

11 novembre 2026

Date di iscrizione allo studio

Primo inviato

8 dicembre 2025

Primo inviato che soddisfa i criteri di controllo qualità

8 dicembre 2025

Primo Inserito (Effettivo)

19 dicembre 2025

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 novembre 2026

Ultimo verificato

1 dicembre 2025

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Pilate Exercises for DED2025

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .